• 
  Marc Thellier, Sandrine Houzé, Bruno Pradine, Renaud Piarroux, Lise Musset, et al.. Assessment of electronic surveillance and knowledge, attitudes, and practice (KAP) survey toward imported malaria surveillance system acceptance in France. JAMIA open, Oxford University Press, 2022, 5 (1), pp.ooac012. ⟨10.1093/jamiaopen/ooac012⟩. ⟨hal-03671130⟩
• 
  Gabriel Malouf, Ronan Flippot, Yiyu Dong, Renzo Dinatale, Ying-Bei Chen, et al.. Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers. Scientific Reports, Nature Publishing Group, 2020, 10 (1), ⟨10.1038/s41598-020-57534-5⟩. ⟨hal-03668020⟩
• 
  M. Debin, Titouan Launay, Louise Rossignol, Fatima Ait El Belghiti, Sylvain Brisse, et al.. Pertussis surveillance results from a French general practitioner network, France, 2017 to 2020. Eurosurveillance, European Centre for Disease Prevention and Control, 2022, 27 (17), pp.2100515. ⟨10.2807/1560-7917.ES.2022.27.17.2100515⟩. ⟨hal-03662371⟩
• 
  Julien Kirchgesner, Rishi Desai, Maria Schneeweiss, Laurent Beaugerie, Seoyoung Kim, et al.. Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy. Pharmacoepidemiology and Drug Safety, Wiley, 2022, 31 (2), pp.167-175. ⟨10.1002/pds.5356⟩. ⟨hal-03657128⟩
• 
  Julien Kirchgesner, Rishi Desai, Laurent Beaugerie, Sebastian Schneeweiss, Seoyoung Kim. Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology, WB Saunders, 2022, 20 (2), pp.314-324.e16. ⟨10.1016/j.cgh.2020.12.030⟩. ⟨hal-03657139⟩
• 
  Julien Kirchgesner, Rishi Desai, Laurent Beaugerie, Seoyoung Kim, Sebastian Schneeweiss. Calibrating Real‐World Evidence Studies Against Randomized Trials: Treatment Effectiveness of Infliximab in Crohn’s Disease. Clinical Pharmacology and Therapeutics, American Society for Clinical Pharmacology and Therapeutics, 2022, 111 (1), pp.179-186. ⟨10.1002/cpt.2304⟩. ⟨hal-03657125⟩
• 
  Julien Kirchgesner, Rishi Desai, Maria Schneeweiss, Laurent Beaugerie, Sebastian Schneeweiss, et al.. Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn's disease.. Gut, BMJ Publishing Group, In press, ⟨10.1136/gutjnl-2022-327002⟩. ⟨hal-03657122⟩
• 
  Rébecca Lajaunie, Lise Cuzin, Romain Palich, Alain Makinson, Firouzé Bani‐sadr, et al.. No increased risk of Kaposi sarcoma relapse in patients with controlled HIV‐1 infection after switching protease inhibitor‐based antiretroviral therapy. HIV Medicine, Wiley, 2021, 23 (3), pp.301 - 306. ⟨10.1111/hiv.13168⟩. ⟨inserm-03651227⟩
• 
  Marion Bailhache, Maeva Monnier, Flore Moulin, Xavier Thierry, Stephanie Vandentorren, et al.. Emotional and attention-deficit/hyperactivity disorder symptoms of preterm vs. full-term children during COVID-19 pandemic restrictions. Pediatric Research, Nature Publishing Group, 2022, ⟨10.1038/s41390-022-02037-4⟩. ⟨hal-03651075⟩
• 
  Marta Lotto, Hélène Fontaine, Fabienne Marcellin, Lauren Périères, Morgane Bureau‐stoltmann, et al.. Hepatitis Delta virus in migrants: The challenge of elimination (ANRS CO22 HEPATHER cohort). Liver International, Wiley-Blackwell, 2021, 42, pp.249 - 252. ⟨10.1111/liv.15106⟩. ⟨inserm-03648173⟩
• 
  Julia Mercier, Claire Calmel, Julie Mésinèle, Erika Sutanto, Fatiha Merabtene, et al.. SLC6A14 Impacts Cystic Fibrosis Lung Disease Severity via mTOR and Epithelial Repair Modulation. Frontiers in Molecular Biosciences, Frontiers Media, 2022, 9, pp.850261. ⟨10.3389/fmolb.2022.850261⟩. ⟨hal-03642658⟩
• 
  Jean Bousquet, Oliver Pfaar, Ioana Agache, Anna Bedbrook, Cezmi Akdis, et al.. ARIA‐EAACI care pathways for allergen immunotherapy in respiratory allergy. Clinical and Translational Allergy, BioMed Central, 2021, 11 (4), pp.e12014. ⟨10.1002/clt2.12014⟩. ⟨hal-03642028⟩
• 
  Paola Nicoletti, Daniel Carr, Sarah Barrett, Laurence Mcevoy, Peter Friedmann, et al.. Beta-lactam-induced immediate hypersensitivity reactions: A genome-wide association study of a deeply phenotyped cohort. Journal of Allergy and Clinical Immunology, Elsevier, 2021, 147 (5), pp.1830-1837.e15. ⟨10.1016/j.jaci.2020.10.004⟩. ⟨hal-03332301⟩
• 
  Clément Massonnaud, Jonathan Roux, Vittoria Colizza, Pascal Crepey. Evaluating COVID-19 Booster Vaccination Strategies in a Partially Vaccinated Population: A Modeling Study. Vaccines, MDPI, 2022, 10 (3), pp.479. ⟨10.3390/vaccines10030479⟩. ⟨hal-03621551⟩
• 
  Joanna Kedra, Thomas Davergne, Ben Braithwaite, Hervé Servy, Laure Gossec. Machine learning approaches to improve disease management of patients with rheumatoid arthritis: review and future directions. Expert Review of Clinical Immunology, Expert Reviews (formerly Future Drugs), 2021, 17 (12), pp.1311-1321. ⟨10.1080/1744666X.2022.2017773⟩. ⟨hal-03621120⟩
• 
  Séverine Deguen, Mary Amuzu, Valentin Simoncic, Wahida Kihal-Talantikite. Exposome and Social Vulnerability: An Overview of the Literature Review. International Journal of Environmental Research and Public Health, MDPI, 2022, 19 (6), pp.3534. ⟨10.3390/ijerph19063534⟩. ⟨hal-03620277⟩
• 
  Cristoforo Incorvaia, Mona Al‐ahmad, Ignacio Ansotegui, Stefania Arasi, Claus Bachert, et al.. Personalized medicine for allergy treatment: Allergen immunotherapy still a unique and unmatched model. Allergy, Wiley, 2021, 76 (4), pp.1041-1052. ⟨10.1111/all.14575⟩. ⟨hal-03613250⟩
• 
  L. Mandelbrot, F. Kieffer, M. Wallon, N. Winer, J. Massardier, et al.. Toxoplasmose pendant la grossesse : proposition actuelle de prise en charge pratique. Gynécologie Obstétrique Fertilité & Sénologie, Elsevier, 2021, 49 (10), pp.782-791. ⟨10.1016/j.gofs.2021.03.003⟩. ⟨inserm-03617466⟩
• 
  Pascal Demoly, Jonathan Corren, Peter Creticos, Frédéric de Blay, Philippe Gevaert, et al.. A 300 IR sublingual tablet is an effective, safe treatment for house dust mite–induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial. Journal of Allergy and Clinical Immunology, Elsevier, 2021, 147 (3), pp.1020 - 1030.e10. ⟨10.1016/j.jaci.2020.07.036⟩. ⟨hal-03613293⟩
• 
  Benjamin Faucher, Rania Assab, Jonathan Roux, Daniel Levy-Bruhl, Cécile Tran Kiem, et al.. Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19. Nature Communications, Nature Publishing Group, 2022, 13 (1), pp.1414. ⟨10.1038/s41467-022-29015-y⟩. ⟨hal-03615409⟩

1 251

481